Zespol Naukowo - Leczniczy Dermatologiczne Centrum Uzdrowiskowe Iwolang Sp. z o.o.
Welcome,         Profile    Billing    Logout  
 7 Trials 
9 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PI
OASIS, NCT04986995: OpicApone Sleep dISorder

Active, not recruiting
4
22
Europe
Opicapone, BIA 9-1067
Bial - Portela C S.A.
Parkinson Disease
06/23
06/23
ADESOS, NCT05469464 / 2021-006707-15: Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis

Active, not recruiting
2b
210
Europe, US
Orismilast modified release tablets, Placebo
UNION therapeutics
Atopic Dermatitis, Skin Diseases
01/24
02/24
NCT04684914 / 2020-002118-42: HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)

Terminated
2
87
Europe, Canada, US
HepTcell, Placebo
Altimmune, Inc., Altimmune, Inc
Hepatitis B, Chronic
03/24
04/24
NCT05686239: A Study to Evaluate RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)

Recruiting
2
234
Europe, US, RoW
RL-007, Placebo
Recognify Life Sciences
Cognitive Impairment Associated With Schizophrenia (CIAS), Cognitive Impairment, Schizophrenia
06/25
07/25
NCT06040346: Open-Label Study to Assess Meplazumab in Adult Patients Diagnosed with Plasmodium Falciparum

Active, not recruiting
2
60
RoW
Meplazumab for Injection
Jiangsu Pacific Meinuoke Bio Pharmaceutical Co Ltd
Malaria
08/25
10/25
TRAK-ER, NCT04985266 / 2020-004022-36: A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer

Recruiting
2
1100
Europe
Palbociclib 125Mg Tab, Fulvestrant injection, Tamoxifen, Letrozole, Exemestane, Anastrozole
Royal Marsden NHS Foundation Trust, Pfizer, AstraZeneca, Institute of Cancer Research, United Kingdom, UNICANCER, Gustave Roussy, Cancer Campus, Grand Paris, Invitae Corporation
ER+ Breast Cancer, HER2-negative Breast Cancer
09/27
09/30
NCT05463263: A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Recruiting
1/2
180
Europe, US
STP938
Step Pharma, SAS
Lymphoma, B-Cell, Lymphoma, T-Cell
12/25
12/25
NCT05756322: The Safety and Tolerability of LBS-007 in Patients with Relapsed or Resistant Acute Leukaemias

Recruiting
1/2
90
US, RoW
LBS-007
Lin BioScience, Inc, Lin BioScience Pty Ltd
Relapsed or Resistant Acute Leukaemias
12/25
12/25
PEPPER, NCT03334006 / 2016-001788-34: Prospective, Randomized Trial of Personalized Medicine with Pentaglobin® After Surgical Infectious Source Control in Patients with Peritonitis

Recruiting
2
200
Europe
Pentaglobin®/Standard of Care
RWTH Aachen University, Biotest
Peritonitis, Sepsis, Septic Shock
09/27
03/28

Download Options